Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$71,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$230,000 |
 |
ModernaMRNA |
$16,000 |
 |
Eli Lilly and CompanyLLY |
-$250,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson | Dec 18, 2025 | Sell | $1K - $15K |
| Julia Letlow | Dec 8, 2025 | Sell | $1K - $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K - $15K |
| Lisa McClain | Oct 31, 2025 | Sell | $1K - $15K |
| Lisa McClain | Oct 30, 2025 | Buy | $1K - $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | Aug 4, 2025 | Buy | $1K - $15K |
| Lisa McClain | Jul 22, 2025 | Buy | $1K - $15K |
| Ritchie Torres | Jul 11, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jun 17, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | May 22, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | May 15, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | May 5, 2025 | Buy | $1K - $15K |
| Julia Letlow | Apr 28, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Apr 17, 2025 | Sell | $50K - $100K |
| Jared Moskowitz | Apr 7, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | Apr 3, 2025 | Buy | $1K - $15K |
| Dwight Evans | Apr 3, 2025 | Sell | $1K - $15K |
| Josh Gottheimer | Apr 1, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Mar 17, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $50K - $100K |
| Julia Letlow | Jan 24, 2025 | Sell | $1K - $15K |
| Jared Moskowitz | Jan 15, 2025 | Buy | $1K - $15K |
| Virginia Foxx | Dec 6, 2024 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Nov 20, 2024 | Buy | $1K - $15K |
| Marjorie Taylor Mrs Greene | Nov 20, 2024 | Buy | $1K - $15K |
| Julia Letlow | Oct 23, 2024 | Buy | $1K - $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
| Ritchie Torres | Sep 26, 2024 | Buy | $1K - $15K |
| Kathy Manning | Jul 2, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | May 29, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Apr 23, 2024 | Sell | $1K - $15K |
| Michael Burgess Republican | Apr 10, 2024 | Sell | $1K - $15K |
| William Keating Democrat | Mar 27, 2024 | Buy | $15K - $50K |
| Rohit Khanna Democrat | Feb 13, 2024 | Buy | $1K - $15K |
FAQ - Congress Trading
Julie Johnson sold AbbVie shares most recently on December 18, 2025.
Jefferson Shreve has bought the most ABBV stock in the last 2 years, with an estimated value of $75,000.
Jefferson Shreve has sold the most ABBV stock in the last 2 years, with an estimated value of $75,000.
According to our estimates, the net value of trades by US politicians for AbbVie in the last 2 years is positive, amounting to $88,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for AbbVie have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
